SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

CORONA Remedies acquires ‘Wokadine’ from Dr. Reddy’s Laboratories

31 Mar 2026 Evaluate

CORONA Remedies has acquired ‘Wokadine’ from Dr. Reddy’s Laboratories. Effective March 30, 2026, the acquisition of Wokadine, ranked second in the Povidone Iodine India market, reinforces CORONA’s commitment to ‘Healing’ as the journey towards holistic recovery and health. This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility. This brand holds strong potential for accelerated growth under CORONA Remedies’ stewardship.

Integrating Wokadine into its portfolio marks CORONA Remedies' entry into the Rs 648 crore Povidone Iodine market. CORONA Remedies' sales & marketing team along with extensive distribution network will work to ensure that this newly acquired portfolio reaches patients across metro, semi-metro, urban, semi-urban and rural areas. Wokadine comprises of 14 SKUs having different applications, helping clinicians treat the ailing community. This acquisition will be fully funded through Company’s internal accruals and cash.

CORONA Remedies is primarily engaged in the business of manufacturing, trading and marketing of pharmaceutical products.

CORONA Remedies Share Price

1712.15 -26.15 (-1.50%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×